PedAM
Pediatric Disease Annotations & Medicines
| Disease | diabetes mellitus, insulin-dependent |
| Symptom | C0497406|overweight |
| Sentences | 7 |
| PubMedID- 21847455 | in another randomized, double-blind clinical trial study of 50 adults, to evaluate the safety and effectiveness of rosiglitazone in the treatment of overweight subjects with type 1 diabetes, to take either insulin and placebo (n = 25) or insulin and rosiglitazone 4 mg twice daily (n = 25) for a period of 8 months, rosiglitazone in combination with insulin resulted in improved glycemic control and blood pressure without an increase in insulin requirements, compared with insulin- and placebo-treated subjects, with the greatest effect of rosiglitazone occurring in subjects with more pronounced markers of insulin resistance. |
| PubMedID- 21968905 | overweight children with type 1 diabetes have a more favourable lipid profile than overweight non-diabetic children. |
| PubMedID- 26073226 | In an open label proof-of-concept study, we included overweight patients diagnosed with type 1 diabetes with an hba1c level over 7.5%. |
| PubMedID- 23102180 | Attention should be given to healthful weight management, especially among overweight youth with type 1 diabetes. |
| PubMedID- 25467623 | Early age at menarche: a risk factor for overweight or obesity in patients with type 1 diabetes living in urban areas. |
| PubMedID- 25405502 | Liver fat content and hepatic insulin sensitivity in overweight patients with type 1 diabetes. |
| PubMedID- 26043285 | The elevation of c-reactive protein levels was more pronounced in overweight adolescents with type 1 diabetes than in adolescents in the c group. |
Page: 1